The distinctive movement disorder of ovarian teratoma-associated encephalitis

Movement Disorders

Volumn 23, Issue 9, 2008, Pages 1256-1261

  Kleinig, Timothy J ^a,b   Thompson, Philip D ^a,c   Matar, Walid ^d   Duggins, Andrew ^d   Kimber, Thomas E ^a   Morris, John G ^d   Kneebone, Christopher S ^a   Blumbergs, Peter C ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b HANSON INSTITUTE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

Dyskinesia; Encephalitis; Ovarian teratoma

Indexed keywords

BENZATROPINE; GLYCOPYRRONIUM BROMIDE; IMMUNOGLOBULIN; LORAZEPAM; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; NEUROLEPTIC AGENT; OLANZAPINE; PREDNISOLONE; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ACUTE PSYCHOSIS; ADOLESCENT; ADULT; AKINETIC MUTISM; ANTIBODY DETECTION; ARTICLE; AUTONOMIC NEUROPATHY; AUTOPSY; BRADYKINESIA; BRAIN SURGERY; BRUXISM; CASE REPORT; CATALEPSY; CATATONIA; CEREBROSPINAL FLUID CYTOLOGY; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; FATALITY; FEMALE; FLUENCY DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERSALIVATION; INFLAMMATORY INFILTRATE; MOTOR DYSFUNCTION; OVARY TERATOMA; PLEOCYTOSIS; PRIORITY JOURNAL; REM SLEEP; RESPIRATORY FAILURE; SLEEP DISORDER;

ADOLESCENT; ADULT; ENCEPHALITIS; FATAL OUTCOME; FEMALE; HUMANS; MOVEMENT DISORDERS; OVARIAN NEOPLASMS; TERATOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 52649109254     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22073     Document Type: Article

References (26)

1. Nokura K, Yamamoto H, Okawara Y, Koga H, Osawa H, Sakai K. Reversible limbic encephalitis caused by ovarian teratoma. Acta Neurol Scand 1997;95:367-373.
2. Okamura H, Oomori N, Uchitomi Y. An acutely confused 15-year-old girl. Lancet 1997;350:488.
3. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-asparlate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
4. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003;160:1233-1241.
5. Tonomura Y, Kataoka H, Hara Y, et al. Clinical analysis of paraneoplastic encephalitis associated with ovarian teratoma. J Neurooncol 2007;84:287-292.
6. Koide R, Shimizu T, Koike K, Datmau J. EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J Neurooncol 2007;81:71-74.
7. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008;70:504-511.
8. Sansing LH, Tuzun E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007;3:291-296.
9. Shimazaki H, Ando Y, Nakano I, Dalmau J, Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry 2007;78:324-325.
10. Schwartz M, Hocherman S. Antipsychotic-induced rabbit syndrome: epidemiology, management and pathophysiology. CNS Drugs 2004;18:213-220.
11. Schwartz MA, Selhorst JB, Ochs AL, et al. Oculomasticatory myorhythmia: a unique movement, disorder ocurring in Whiple's disease. Ann Neurol 1986;20:677-683.
12. Deuschl G, Wilms H. Clinical spectrum and physiology of palatal tremor. Mov Disord 2002;17 (Suppl 2):S63-S66.
13. Blunt SB, Lane RJ, Turjanski N, Perkin GD. Clinical features and management of two cases of encephalitis lethargica. Mov Disord 1997;12:354-359.
14. Shill HA, Stacy MA. Malignant catatonia secondary to sporadic encephalitis lethargica. J Neurol Neurosurg Psychiatry 2000;69: 402-403.
15. Raghav S, Seneviratne J, McKelvie PA, Chapman C, Talman PS, Kempster PA. Sporadic encephalitis lethargica. J Clin Neurosci 2007;14:696-700.
16. Howard RS, Lees AJ. Encephalitis lethargica. A report of four recent cases. Brain 1987; 110 (Part 1): 19-33.
17. McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med 1981;10:237-242.
18. Taittonen MT, Kirvela OA, Aantaa R, Kanto JH. The effect of clonidine or midazolam premedication on perioperative responses during ketamine anesthesia. Anesth Analg 1998;87:161-167.
19. Haas DA, Harper DG. Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia. Anesth Prog 1992; 39:61-68.
20. Heinz P, Geelhoed GC, Wee C, Pascoe EM. Is atropine needed with ketamine sedation? A prospective, randomised, double blind study. Emerg Med J 2006;23:206-209.
21. Ilkiw JE, Suter CM, McNeal D, Farver TB, Steffey EP. The effect of intravenous administration of variable-dose midazolam after fixed-dose ketamine in healthy awake cats. J Vet Pharmacol Ther 1996; 19:217-224.
22. Shiigi Y, Casey DE. Effects of benztropine on ketamine-induced behaviors in Cebus monkeys. Behav Pharmacol 2001;12:293-298.
23. Marco LA, Joshi RS. A ketamine-induced rat model of tardive dyskinesia. Prog Neurobiol 1992;38:571-600.
24. Rigby M, Le Bourdelles B, Heavens RP, et al. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience 1996;73:429-447.
25. Dubuc R, Brocard F, Antri M, et al. Initiation of locomotion in lampreys. Brain Res Rev 2008;57:172-182.
26. Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008;79:324-326.